STAAR Surgical Company (STAA)
NASDAQ
Closed
Oct 20, 2026
Day's Range
21.8552 wk Range
15.59Overview - STAA - STAAR Surgical Company
Key Statistics
Valuation
Enterprise Value
941.07M
P/E (Trailing)
‪270.87‬
P/E (Forward)
‪19.49‬
PEG Ratio
‪-1.84‬
Price / Sales (TTM)
‪3.19‬
Price / Book
‪2.97‬
EV / EBITDA
‪18.91‬
Profitability
Gross Margin
‪74.54%‬
Profit Margin
‪1.13%‬
Operating Margin
‪10.88%‬
Return on Assets
‪5.64%‬
Return on Equity
‪1.09%‬
Ownership
Shares Outstanding
50.12M
Float
26.12M
Short % of Shares Outstanding
‪15.55%‬
Held by Insiders
‪0.85%‬
Held by Institutions
‪111.56%‬
Price stats
Beta
‪1.17‬
50-Day Avg
‪22.92‬
200-Day Avg
‪23.61‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
11 analysts
Average price target
‪$ 27.90‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - STAA - STAAR Surgical Company
Peers - STAA - STAAR Surgical Company
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
- STAANASDAQSTAAR Surgical Company1.10BMarket Cap-23.81%52-week change270.88P/E (Trailing)‪1.13%‬Profit Margin
- ISRGNASDAQIntuitive Surgical Inc.150.74BMarket Cap-7.45%52-week change48.93P/E (Trailing)‪28.44%‬Profit Margin
- MDLNNASDAQMedline Inc. Class A Common Stock47.34BMarket Cap-16.51%52-week change88.10P/E (Trailing)‪2.31%‬Profit Margin
- RGENNASDAQRepligen Corporation11.13BMarket Cap+11.90%52-week change240.30P/E (Trailing)‪5.29%‬Profit Margin
- COONASDAQThe Cooper Companies, Inc.11.01BMarket Cap-29.43%52-week change19.91P/E (Trailing)‪13.46%‬Profit Margin
- ALGNNASDAQAlign Technology, Inc.9.97BMarket Cap+7.75%52-week change24.55P/E (Trailing)‪9.99%‬Profit Margin
- MMSINASDAQMerit Medical Systems, Inc.5.32BMarket Cap+6.71%52-week change36.86P/E (Trailing)‪9.22%‬Profit Margin
Profile Summary - STAA - STAAR Surgical Company
About
STAAR Surgical Company is a medical technology company that designs, develops, manufactures, and markets implantable lenses for the eye and companion delivery systems. Its core product line includes Implantable Collamer® Lenses used in refractive surgery to address visual disorders such as myopia, hyperopia,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
